NOCIL LTD. - 500730 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Enclosed herewith the Compliance Certificate received from KFin Technologies Private Limited, the Registrar and Shares Transfer Agent of the Company, for the period from 1st July,2021 to 30th September ,2021. This report is submitted in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. We request you to take the same on your records. NOCIL LTD. - 500730 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- Amit K VyasDesignation :- Company Secretary and Compliance Officer NOCIL Ltd - 500730 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings NOCIL Ltd - 500730 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the provisions of the aforesaid Regulation, Kfin Technologies Private Limited, the Company''s Registrar and Transfer Agent (''RTA''), has informed about the request for issue of duplicate share certificate . We have also enclosed a letter dated 22nd September 2021 received from Kfin, giving the abovementioned details. We will initiate the process of issue of duplicate share certificate on receipt of the requisite documents from the shareholder and necessary approvals. NOCIL Ltd - 500730 - Closure of Trading Window
It is hereby intimated that the trading window of NOCIL Limited ('the Company') would be closed with the close of business hours from Thursday, 30th September 2021 for the designated and connected persons till the conclusion of 48 hours after the declaration of Unaudited Financial Results for the quarter and half yearly period ending on 30th September 2021, as approved by the Board of Directors. This is for your information and records. NOCIL Ltd - 500730 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings NOCIL Ltd - 500730 - Minutes Of The 59Th Annual General Meeting ('AGM') Of NOCIL Limited ('The Company') Held On Tuesday, 3Rd August, 2021
With reference to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we enclose herewith the Minutes of the Proceedings of the 59th Annual General Meeting of the Company held on Tuesday, 3rd August, 2021 through Video Conferencing/ Other Audio-Visual means. Kindly take the same on your records and acknowledge receipt.
NOCIL: Demand pick-up, 'China plus' to provide growth momentum
On the exports front, enquiries from new customers have increased as MNC clients want to contain the China supply-chain risk NOCIL LTD. - 500730 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the provisions of the aforesaid Regulation, Kfin Technologies Private Limited, the Company''s Registrar and Transfer Agent (''RTA''), has informed about the request for issue of duplicate share certificate . We have also enclosed a letter dated 13th August 2021 received from Kfin, giving the abovementioned details. We will initiate the process of issue of duplicate share certificate on receipt of the requisite documents from the shareholder and necessary approvals. NOCIL LTD. - 500730 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
We wish to inform that pursuant to the Company's Employee Stock Option Scheme- 2007' as Amended, the Nomination and Remuneration Committee have allotted 45,700 Equity shares of the face value of Rs. 10/- each on 13th August 2021 to the Senior Management Personnel of the Company. The details of the Company's Equity Share Capital before and after the issue of 45,700 Equity Shares as aforesaid are given in the attached document. We request you to take the above on records and acknowledge receipt